Carcinoembryonic Antigen (CEA) / CD66 Antibody, IgG2a, Clone: [C66/1009], Mouse, Monoclonal

Catalog Number: NBT-1048-MSM5-CF488-100T
Article Name: Carcinoembryonic Antigen (CEA) / CD66 Antibody, IgG2a, Clone: [C66/1009], Mouse, Monoclonal
Biozol Catalog Number: NBT-1048-MSM5-CF488-100T
Supplier Catalog Number: 1048-MSM5-CF488-100T
Alternative Catalog Number: NBT-1048-MSM5-CF488-100T-0.5,NBT-1048-MSM5-CF488-100T-500
Manufacturer: NeoBiotechnologies
Host: Mouse
Category: Antikörper
Application: FC, IF
Species Reactivity: Human
Immunogen: Recombinant full-length human CEA protein
Alternative Names: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66, Biliary Glycoprotein (BGP-1)
This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.
Clonality: Monoclonal
Clone Designation: [C66/1009]
Molecular Weight: 80-200kDa
Isotype: IgG2a
NCBI: 1048
UniProt: P06731
Form: Antibody purified from Bioreactor Concentrate by Protein A/G and conjugated to various reporter molecules. Prepared in 10mM PBS with 0.05% BSA and 0.05% azide. Contact us if you require this Ab in a different format.
Antibody Type: Monoclonal Antibody
Application Notes: Flow Cytometry (5ul per test per one million cells or 5ul per 100ul of whole blood),Immunofluorescence (1:50-1:100),Optimal dilution for a specific application should be determined.